The Patent Cliff Isn’t a Pipeline Problem. It’s a Leadership Problem
Between 2025 and 2030, biopharma faces its steepest loss-of-exclusivity wave on record. Among the top 15 companies alone, roughly $275B
While Eli Lilly and Novo Nordisk Compete for Market Share, They’re Really Competing for People
Eli Lilly and Novo Nordisk are competing over $150B in future obesity drug sales. But behind the ad lawsuits and
The $81 Billion Problem No One’s Solving: Why Oncology’s Biggest Bottleneck Isn’t Science, It’s People
The CAR-T therapy market is projected to grow from $5.76 billion in 2025 to $81.45 billion by 2035 — a
Global Pharma Job Outlook in 2026
2026 has hit, and the industry appears to be undergoing an interesting structural shift. We’ve passed the post-pandemic correction and
Pharma’s Pay Problem: The One Data Point Companies Don’t Want to Share
Let’s talk about something pharma doesn’t often put in the spotlight, pay transparency. For all the buzzwords about innovation, integrity,
Pharma in the TikTok Era. Can Social Media Actually Improve Public Health?
Pharma used to speak through brochures, TV ads, and the fine print on a pill bottle. Today? It’s showing up
World Cancer Day: Advancing Innovation and Prevention in Oncology
Today, on World Cancer Day, we reflect on the global impact of cancer and the urgent need for innovative solutions
Navigating Industry Change – Opportunities in Pharma’s Evolution
The pharmaceutical industry’s restructuring and offshoring trends in Switzerland have created understandable anxiety among professionals. However, this transformation also presents
The Talent Gap in Life Sciences and Technology: A European Perspective
In recent years, the life sciences and technology sectors in Switzerland and the greater-Europe area have faced significant challenges in
The Present Job Market
The life sciences sector, like many others, is grappling with significant challenges due to ongoing economic difficulties. From January to